TSH Biopharm Corporation Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	139.26	113.09	61.99	61.89	47.11
Depreciation & Amortization	25.46	27.56	21.34	20.61	9.65
Other Amortization	1.28	1.4	1.23	0.91	0.14
Loss (Gain) From Sale of Assets	-1.11	0.87	0.04	0.06	0
Asset Writedown & Restructuring Costs	-	8.8	-	-	4.15
Provision & Write-off of Bad Debts	0.9	0.76	-1.93	3.04	-0.1
Other Operating Activities	37.64	35.14	-8.83	-1.3	-15.64
Change in Accounts Receivable	-99.41	48.61	-5.52	-10.41	9.05
Change in Inventory	20.33	-44.91	-11.01	-13.95	4.69
Change in Accounts Payable	-13.99	-43.14	-5.93	-49.46	6.33
Change in Unearned Revenue	2.21	-0.8	-3.59	5.23	-
Change in Other Net Operating Assets	26.95	36.4	-13.93	17.74	3.34
Operating Cash Flow	139.52	183.77	33.87	34.35	68.71
Operating Cash Flow Growth	-24.08%	442.54%	-1.40%	-50.00%	491.74%
Capital Expenditures	-4.52	-1.73	-5.38	-3.73	-0.38
Sale of Property, Plant & Equipment	-	0.3	-	0.03	-
Cash Acquisitions	-	-242.87	-	-	-
Divestitures	1.47	-	-	-	-
Sale (Purchase) of Intangibles	-5.88	-1.02	-0.18	-15	-
Investment in Securities	-158.95	127.94	167.87	44.67	-14.28
Other Investing Activities	3.07	6.99	-1.29	7.42	4.6
Investing Cash Flow	-164.82	-110.38	161.02	33.4	-10.06
Short-Term Debt Issued	-	-	-	20	-
Long-Term Debt Issued	-	-	-	30	-
Total Debt Issued	-	-	-	50	-
Short-Term Debt Repaid	-	-	-20	-61.07	-
Long-Term Debt Repaid	-12.24	-12.54	-35.73	-20.93	-4.35
Total Debt Repaid	-12.24	-12.54	-55.73	-82	-4.35
Net Debt Issued (Repaid)	-12.24	-12.54	-55.73	-32	-4.35
Common Dividends Paid	-81.4	-49.15	-61.44	-57.6	-69.12
Other Financing Activities	-4.86	-	9.99	0.2	-
Financing Cash Flow	-98.51	-61.69	-107.18	-89.4	-73.46
Foreign Exchange Rate Adjustments	-	0.06	-0.03	0.03	-
Net Cash Flow	-123.8	11.76	87.68	-21.62	-14.81
Free Cash Flow	135	182.04	28.49	30.62	68.33
Free Cash Flow Growth	-25.84%	538.93%	-6.96%	-55.18%	604.75%
Free Cash Flow Margin	10.10%	16.32%	3.51%	4.13%	16.52%
Free Cash Flow Per Share	3.51	4.74	0.74	0.80	1.78
Cash Interest Paid	0.8	0.46	0.69	0.7	0.08
Cash Income Tax Paid	51.34	19.24	15.9	13.98	23.74
Levered Free Cash Flow	85.28	138.94	8.75	-18.85	62.7
Unlevered Free Cash Flow	85.77	139.23	9.18	-18.41	62.75
Change in Working Capital	-63.9	-3.84	-39.97	-50.86	23.41

Source: S&P Global Market Intelligence. Standard template. Financial Sources.